Literature DB >> 20654673

Gastric dysmotility in healthy first-degree relatives of patients with schizophrenia.

Sandy Berger1, Michael Hocke, Karl-Jürgen Bär.   

Abstract

Gastric dysmotility has been reported in patients suffering from major depression or schizophrenia. An increased sympathetic activity modulating the gastric pacemaker located in the antrum of the stomach has been suggested as the underlying pathology. Similar to patients suffering from schizophrenia, their first-degree relatives showed alterations in cardiac autonomic modulation. Here we aimed to investigate gastric myoelectrical activity in healthy relatives of patients suffering from paranoid schizophrenia. Electrogastrography (EGG) was performed before and after test meal ingestion in 20 patients with paranoid schizophrenia, 20 of their first-degree relatives and 20 healthy matched controls. Autonomic and abdominal symptoms were assessed by the autonomic symptom score as previously reported. Autonomic parameters were correlated with the positive and negative syndrome scale (PANSS). Only minimal differences were observed before test meal ingestion between relatives and controls. In contrast, after test meal ingestion we observed a significantly increased tachygastria within the signal of the gastric pacemaker in relatives compared to controls, whereas normogastria was reduced. Significant difference between relatives and controls were also found for postprandial ICDF (instability coefficient of dominant frequency) and slow wave, which represents the dominant frequency of gastric pacemaker activity, indicating gastric dysmotility in relatives. Between relatives and patients just a difference for ICDP (instability coefficient of dominant power) was observed. After stimulation of the enteric nervous system we have observed an increased sympathetic modulation in first-degree relatives of patients suffering from schizophrenia. This result adds evidence to an ongoing debate on the genetic influence of autonomic dysfunction in the disease.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20654673     DOI: 10.1016/j.pnpbp.2010.07.013

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  6 in total

1.  Clozapine-induced paralytic ileus: a case report.

Authors:  Birmay Cam; Mehmet Zeki Tanircan
Journal:  Ther Adv Psychopharmacol       Date:  2014-08

Review 2.  Clozapine and Gastrointestinal Hypomotility.

Authors:  Dan Cohen
Journal:  CNS Drugs       Date:  2017-12       Impact factor: 5.749

3.  The phrenic component of acute schizophrenia--a name and its physiological reality.

Authors:  Karl-Jürgen Bär; Tobias Rachow; Steffen Schulz; Katharina Bassarab; Stefanie Haufe; Sandy Berger; Kathrin Koch; Andreas Voss
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

4.  Risperidone associated paralytic ileus in schizophrenia.

Authors:  Parthasarathy Ramamourthy; Arunkumar Kumaran; Shivanand Kattimani
Journal:  Indian J Psychol Med       Date:  2013-01

5.  High prevalence of underweight and undernutrition in Japanese inpatients with schizophrenia: a nationwide survey.

Authors:  Takuro Sugai; Yutaro Suzuki; Manabu Yamazaki; Kazutaka Shimoda; Takao Mori; Yuji Ozeki; Hiroshi Matsuda; Norio Sugawara; Norio Yasui-Furukori; Yoshitake Minami; Kurefu Okamoto; Toyoaki Sagae; Toshiyuki Someya
Journal:  BMJ Open       Date:  2015-12-09       Impact factor: 2.692

6.  A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies.

Authors:  Eva A Malt; Katalin Juhasz; Ulrik F Malt; Thomas Naumann
Journal:  Front Behav Neurosci       Date:  2016-03-30       Impact factor: 3.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.